Trial Profile
A double-blind, placebo-controlled, enriched enrolment, randomized-withdrawal study to evaluate the efficacy and safety of 2PX in patients with pain due to osteoarthritis of the knee
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2019
Price :
$35
*
At a glance
- Drugs 2 PX (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Acronyms 2PX in OA
- Sponsors SantoSolve
- 27 Jan 2008 New trial record.
- 18 Jan 2008 Primary endpoint achieved; results reported by SantoSolve.